Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Colorectal Neoplasms

Free Subscription Articles published in Br J Surg Retrieve available abstracts of 43 articles: HTML format

Single Articles

February 2026
1. TAN JH, Yan IWJ, Chang JHE, Khoo MSQ, et al
   Non-operative management of mismatch repair-deficient (dMMR) / micro satellite instability-high (MSI-H) colorectal cancer treated with immunotherapy: systematic review and meta-analysis.
   Br J Surg. 2026;113:znaf284.
   PubMed    
   
   
   December 2025
2. RUBIO-ALARCON C, Georgiadis A, Franken IA, Wang H, et al
   Circulating tumour DNA in patients with stage III colon cancer: multicentre prospective PROVENC3 study.
   Br J Surg. 2025;113:znaf281.
   PubMed     Abstract available
   
   
   November 2025
3. 
   Multiple primary tumours in early-onset colorectal cancer: deciphering the risk.
   Br J Surg. 2025;112:znaf244.
   PubMed    
   
   
   September 2025
4. TAIEB J, Karoui M
   Challenges of decision-making after treatment with immunotherapy in metastatic deficient DNA mismatch repair/microsatellite unstable colorectal cancer.
   Br J Surg. 2025;112:znaf178.
   PubMed    
   
   
   
5. REESE T, Bjork D, Longva AMH, Kiim KS, et al
   Oncological safety of portal vein embolization without prior tumour clearance in the future liver remnant followed by one-stage hepatectomy for bilateral colorectal liver metastases.
   Br J Surg. 2025;112:znaf198.
   PubMed     Abstract available
   
   
   
6. 
   Covered versus uncovered endoluminal stenting in the acute management of obstructing colorectal cancer in the palliative setting: randomized clinical trial (CReST2).
   Br J Surg. 2025;112:znaf117.
   PubMed     Abstract available
   
   
   
7. HELLIWELL JA, Chilton CH, Young C, Clark EV, et al
   Perioperative changes in the microbiome during rectal cancer surgery: exploratory analysis of the National Institute for Health and Care Research (NIHR) IntAct trial.
   Br J Surg. 2025;112:znaf199.
   PubMed     Abstract available
   
   
   
8. PRATA I, Tanaka MD, Glimelius B, Nagtegaal ID, et al
   Factors influencing locoregional recurrence rates in locally advanced rectal cancer after total neoadjuvant treatment versus chemoradiotherapy in the RAPIDO trial.
   Br J Surg. 2025;112:znaf190.
   PubMed     Abstract available
   
   
   August 2025
9. VU JK, Brown KGM, Solomon MJ, Ng KS, et al
   Patterns and outcomes of disease recurrence after pelvic exenteration for locally recurrent rectal cancer.
   Br J Surg. 2025;112:znaf154.
   PubMed     Abstract available
   
   
   May 2025
10. FLETCHER JA, Corr A, Drami I, Taylor C, et al
    Enhancing decision-making and patient comprehension in complex rectal cancer surgery through personalized three-dimensional imaging: randomized feasibility study.
    Br J Surg. 2025;112:znaf116.
    PubMed     Abstract available
    
    
    
11. 
    Correction to: Tumour deposit count is an independent prognostic factor in colorectal cancer-a population-based cohort study.
    Br J Surg. 2025;112:znaf135.
    PubMed    
    
    
    March 2025
12. GEUBELS BM, Grotenhuis BA, van den Esschert AJ, Lambregts DMJ, et al
    National implementation of Watch-and-Wait in patients with rectal cancer.
    Br J Surg. 2025;112:znaf040.
    PubMed     Abstract available
    
    
    
13. MOOSAVI SH, Kryeziu K, Eilertsen IA, Nunes L, et al
    Molecular prognostic factors for liver transplantation of unresectable metastatic colorectal cancer.
    Br J Surg. 2025;112:znaf072.
    PubMed    
    
    
    
14. 
    Metachronous colorectal cancer risks after extended or segmental resection in MLH1, MSH2, and MSH6 Lynch syndrome: multicentre study from the Prospective Lynch Syndrome Database.
    Br J Surg. 2025;112:znaf061.
    PubMed     Abstract available
    
    
    
15. HAMM JJM, van den Berg R, Andrinopoulou ER, Zwanenburg ES, et al
    Adjuvant hyperthermic intraperitoneal chemotherapy in patients with colon cancer at high risk of peritoneal metastases: individual patient data meta-analysis.
    Br J Surg. 2025;112:znaf076.
    PubMed     Abstract available
    
    
    
16. SELIGMANN JF
    Colorectal cancer staging-time for a re-think on TNM?
    Br J Surg. 2025;112:znaf047.
    PubMed    
    
    
    
17. PANG K, Liu X, Yao H, Lin G, et al
    Impact of PD1 blockade added to neoadjuvant chemoradiotherapy on rectal cancer surgery: post-hoc analysis of the randomized POLARSTAR trial.
    Br J Surg. 2025;112:znaf057.
    PubMed     Abstract available
    
    
    December 2024
18. LUNDSTROM S, Agger E, Lydrup ML, Jorgren F, et al
    Tumour deposit count is an independent prognostic factor in colorectal cancer-a population-based cohort study.
    Br J Surg. 2024;112:znae309.
    PubMed     Abstract available
    
    
    October 2024
19. CAI ZH, Guo YC, Ye K, Xiao Y, et al
    Infrapyloric and gastroepiploic lymph node metastasis in right transverse colon cancer (InCLART study): multicentre, prospective, observational study.
    Br J Surg. 2024;111:znae272.
    PubMed    
    
    
    September 2024
20. WENZELBERG CL, Rogmark P, Ekberg O, Petersson U, et al
    Reinforced tension-line suture after laparotomy: early results of the Rein4CeTo1 randomized clinical trial.
    Br J Surg. 2024;111:znae265.
    PubMed     Abstract available
    
    
    August 2024
21. PAOLUCCI I, Albuquerque Marques Silva J, Lin YM, Laimer G, et al
    Identification of A0 minimum ablative margins for colorectal liver metastases: multicentre, retrospective study using deformable CT registration and artificial intelligence-based autosegmentation.
    Br J Surg. 2024;111:znae165.
    PubMed     Abstract available
    
    
    
22. SOREIDE K, Kok NFM
    Curative-intent ablation margins (A0) for colorectal liver metastasis: more burning questions.
    Br J Surg. 2024;111:znae184.
    PubMed    
    
    
    
23. ZUKAUSKAITE K, Horvath A, Gricius Z, Kvietkauskas M, et al
    Impact of mechanical bowel preparation on the gut microbiome of patients undergoing left-sided colorectal cancer surgery: randomized clinical trial.
    Br J Surg. 2024;111:znae213.
    PubMed     Abstract available
    
    
    
24. VALDMAN A, Marsk R, Karimi M, Asklid D, et al
    Surgical outcomes following total neoadjuvant therapy in rectal cancer with short-course radiotherapy using protons or photons: initial safety data from the PRORECT randomized trial.
    Br J Surg. 2024;111:znae241.
    PubMed    
    
    
    
25. WILLIAMS H, Yuval JB, Verheij FS, Miranda J, et al
    Baseline MRI predictors of successful organ preservation in the Organ Preservation in Rectal Adenocarcinoma (OPRA) trial.
    Br J Surg. 2024;111:znae246.
    PubMed     Abstract available
    
    
    
26. OZCAN C, Colak T, Turkmenoglu O, Berkesoglu M, et al
    Impact of small-bite (5 mm) fascial closure on the incidence of incisional hernia following open colorectal cancer surgery: randomized clinical trial.
    Br J Surg. 2024;111:znae189.
    PubMed     Abstract available
    
    
    
27. BOZKURT E, Sijberden JP, Langella S, Cipriani F, et al
    Laparoscopic versus open right hepatectomy for colorectal liver metastases after portal vein embolization: international multicentre study.
    Br J Surg. 2024;111:znae181.
    PubMed     Abstract available
    
    
    
28. PEDRAZZANI C, Turri G, Ostuzzi G, Barbui C, et al
    Comment on: Total neoadjuvant therapy versus standard neoadjuvant treatment strategies for the management of locally advanced rectal cancer: network meta-analysis of randomized clinical trials.
    Br J Surg. 2024;111:znae209.
    PubMed    
    
    
    
29. DONNELLY M, Ryan OK, Ryan EJ, Winter DC, et al
    Author response to: Comment on: Total neoadjuvant therapy versus standard neoadjuvant treatment strategies for the management of locally advanced rectal cancer: network meta-analysis of randomized clinical trials.
    Br J Surg. 2024;111:znae211.
    PubMed    
    
    
    July 2024
30. MARGONIS GA, Wang JJ, Boerner T, Moretto R, et al
    Hepatectomy versus systemic therapy for liver-limited BRAF V600E-mutated colorectal liver metastases: multicentre retrospective study.
    Br J Surg. 2024;111:znae176.
    PubMed     Abstract available
    
    
    
31. JOYCE A, Drake TM, Hampson C, Monaghan A, et al
    Comment on: Effect of centre volume on pathological outcomes and postoperative complications after surgery for colorectal cancer: results of a multicentre national study.
    Br J Surg. 2024;111:znae194.
    PubMed    
    
    
    
32. ROTTOLI M, Spinelli A, Pellino G, Gori A, et al
    Author response to: Comment on: Effect of centre volume on pathological outcomes and postoperative complications after surgery for colorectal cancer: results of a multicentre national study.
    Br J Surg. 2024;111:znae193.
    PubMed    
    
    
    
33. GUAN X, Zhao X, Jiao S, Hao R, et al
    Circulating immune cell profile in patients with colorectal cancer.
    Br J Surg. 2024;111:znae186.
    PubMed    
    
    
    June 2024
34. BAO QR, Ferrari S, Capelli G, Chiloiro G, et al
    Oncological outcomes of patients not undergoing Total Mesorectal Excision after local excision: rethinking surgical indications.
    Br J Surg. 2024;111:znae144.
    PubMed    
    
    
    May 2024
35. ZAFFARONI G, Mannucci A, Koskenvuo L, de Lacy B, et al
    Updated European guidelines for clinical management of familial adenomatous polyposis (FAP), MUTYH-associated polyposis (MAP), gastric adenocarcinoma, proximal polyposis of the stomach (GAPPS) and other rare adenomatous polyposis syndromes: a joint EH
    Br J Surg. 2024;111:znae070.
    PubMed     Abstract available
    
    
    
36. OLTHOF K, Smit J, Fusaglia M, Kok N, et al
    A surgical navigation system to aid the ablation of vanished colorectal liver metastases.
    Br J Surg. 2024;111:znae110.
    PubMed    
    
    
    
37. GABRIELE R, Campagnol M, Iannone I, Sapienza P, et al
    Faecal occult blood and sigmoidoscopy data from the Italian national screening programme.
    Br J Surg. 2024;111:znae131.
    PubMed    
    
    
    April 2024
38. KRUL MF, Kok NFM, Osmani H, Buisman FE, et al
    Hepatic arterial infusion pump chemotherapy combined with systemic chemotherapy for borderline resectable and unresectable colorectal liver metastases: phase II feasibility study.
    Br J Surg. 2024;111:znae089.
    PubMed     Abstract available
    
    
    March 2024
39. CUK P, Tiskus M, Moller S, Lambertsen KL, et al
    Surgical stress response in robot-assisted versus laparoscopic surgery for colon cancer (SIRIRALS): randomized clinical trial.
    Br J Surg. 2024;111:znae049.
    PubMed     Abstract available
    
    
    
40. GLYNNE-JONES R, Harrison M
    Colorectal cancer para-aortic lymph node metastases: surgery should not be considered.
    Br J Surg. 2024;111:znad443.
    PubMed    
    
    
    
41. PEACOCK O
    Colorectal cancer para-aortic lymph node metastases-surgery should be considered.
    Br J Surg. 2024;111:znad445.
    PubMed    
    
    
    
42. PEREA J, Garcia JL, Corchete LA, Marti M, et al
    Chromosomal breaks: another differential gap between early-onset and late-onset colorectal cancers.
    Br J Surg. 2024;111:znae041.
    PubMed    
    
    
    
43. MARTIN-CULLELL B, Virgili AC, Riera P, Fumagalli C, et al
    Histopathological, Clinical, And Molecular (HICAM) score for patients with colorectal liver metastases.
    Br J Surg. 2024;111:znae016.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum